Does possession of apolipoprotein E ε4 benefit cognitive function in healthy young adults?

被引:37
作者
Bunce, David [1 ,2 ]
Anstey, Kaarin J. [2 ]
Burns, Richard [2 ]
Christensen, Helen [2 ]
Easteal, Simon [3 ]
机构
[1] Brunel Univ, Ctr Cognit & Neuroimaging, Dept Psychol, London UB8 3PH, England
[2] Australian Natl Univ, Mental Hlth Res Ctr, Canberra, ACT, Australia
[3] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia
基金
澳大利亚国家健康与医学研究理事会;
关键词
Age; APOE; Cognitive function; Antagonistic pleiotropy; ALZHEIMER-DISEASE; APOE GENOTYPE; FMRI EVIDENCE; OLDER-ADULTS; POPULATION; ACTIVATION; PATTERNS; ALLELE; STATE; RISK;
D O I
10.1016/j.neuropsychologia.2011.02.042
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
010107 [宗教学]; 030301 [社会学]; 070906 [古生物学及地层学(含古人类学)];
摘要
There is considerable evidence that the apolipoprotein E (APOE) epsilon 4 allele is associated with cognitive deficits in older persons, and is a risk factor for dementia. However, it has recently been suggested that possession of the epsilon 4 allele may benefit cognition in early adulthood. We tested this possibility in 5445 community-dwelling persons aged 20-24,40-44, and 60-64 years using a comprehensive battery of cognitive measures. As the APOE epsilon 2 allele may offer protection against cognitive deficits, in order to robustly test the hypothesis, we removed persons carrying this allele from the analyses. Older persons with possible dementia were also removed. We found no evidence of higher cognitive performance in young epsilon 4 carriers, or cognitive deficits in older epsilon 4 carriers. This did not change when a range of health variables were taken into account. We conclude that it is premature to suppose epsilon 4-related benefits to cognition in healthy young adulthood and findings consistent with this hypothesis may have been related to methodological issues, or the pathology of the sample investigated. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1693 / 1697
页数:5
相关论文
共 30 条
[1]
Prodromal Alzheimer's Disease: Successive Emergence of the Clinical Symptoms [J].
Amieva, Helene ;
Le Goff, Melanie ;
Millet, Xavier ;
Orgogozo, Jean Marc ;
Peres, Karine ;
Barberger-Gateau, Pascale ;
Jacqmin-Gadda, Helene ;
Dartigues, Jean Francois .
ANNALS OF NEUROLOGY, 2008, 64 (05) :492-498
[2]
[Anonymous], 1992, SPOT THE WORD TEST
[3]
fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease [J].
Bondi, MW ;
Houston, WS ;
Eyler, LT ;
Brown, GG .
NEUROLOGY, 2005, 64 (03) :501-508
[4]
Patterns of brain activation in people at risk for Alzheimer's disease [J].
Bookheimer, SY ;
Strojwas, MH ;
Cohen, MS ;
Saunders, AM ;
Pericak-Vance, MA ;
Mazziotta, JC ;
Small, GW .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (07) :450-456
[5]
APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging [J].
Bunce, D ;
Fratiglioni, L ;
Small, BJ ;
Winblad, B ;
Bäckman, L .
NEUROLOGY, 2004, 63 (05) :816-821
[6]
The association of APOE genotype and cognitive decline in interaction with risk factors in a 65-69 year old community sample [J].
Christensen H. ;
Batterham P.J. ;
Mackinnon A.J. ;
Jorm A.F. ;
Mack H.A. ;
Mather K.A. ;
Anstey K.J. ;
Sachdev P.S. ;
Easteal S. .
BMC Geriatrics, 8 (1)
[7]
Cohen J., 1988, Statistical power analysis for the behavioral sciences, VSecond
[8]
PROTECTIVE EFFECT OF APOLIPOPROTEIN-E TYPE-2 ALLELE FOR LATE-ONSET ALZHEIMER-DISEASE [J].
CORDER, EH ;
SAUNDERS, AM ;
RISCH, NJ ;
STRITTMATTER, WJ ;
SCHMECHEL, DE ;
GASKELL, PC ;
RIMMLER, JB ;
LOCKE, PA ;
CONNEALLY, PM ;
SCHMADER, KE ;
SMALL, GW ;
ROSES, AD ;
HAINES, JL ;
PERICAKVANCE, MA .
NATURE GENETICS, 1994, 7 (02) :180-184
[9]
Delis DC, 1987, The California verbal learning test
[10]
Temporal lobe functional activity and connectivity in young adult APOE ε4 carriers [J].
Dennis, Nancy A. ;
Browndyke, Jeffrey N. ;
Stokes, Jared ;
Need, Anna ;
Buke, James R. ;
Welsh-Bohmer, Kathleen A. ;
Cabeza, Roberto .
ALZHEIMERS & DEMENTIA, 2010, 6 (04) :303-311